Results 31 to 40 of about 16,246 (218)

Mini erythema migrans - A sign of early Lyme borreliosis [PDF]

, 2006
Background: An erythema migrans (EM) remaining smaller than 5 cm in diameter, called mini EM by us, has not been addressed in detail. Objective: To study the significance of the mini EM as a sign of Lyme borreliosis. Methods: Patients with suspected mini
Weber, K., Wilske, B.
core   +1 more source

Lyme disease. Pediatric Aspects (II Part)

Zdorovʹe Rebenka, 2014
Up to 25 % of all patients with Lyme borreliosis — children aged 5–9 years. In children also have three clinical and pathogenetic stages of Lyme disease.
V.V. Mavrutenkov
doaj   +1 more source

Gender disparity between cutaneous and non-cutaneous manifestations of Lyme borreliosis.

PLoS ONE, 2013
Cutaneous manifestations of Lyme borreliosis in Europe include erythema migrans (EM) and acrodermatitis chronica atrophicans (ACA); the most common non-cutaneous manifestations are Lyme neuroborreliosis (LNB) and Lyme arthritis. The purpose of this study
Franc Strle, Gary P Wormser, Paul Mead, Kanthi Dhaduvai, Michael V Longo, Omosalewa Adenikinju, Sandeep Soman, Yodit Tefera, Vera Maraspin, Stanka Lotrič-Furlan, Katarina Ogrinc, Jože Cimperman, Eva Ružić-Sabljić, Daša Stupica   +13 more
doaj   +1 more source

Update of the Swiss guidelines on post-treatment Lyme disease syndrome. [PDF]

, 2016
Lyme borreliosis is caused by Borrelia burgdorferi sensu lato infection, which responds well to antibiotic therapy in the overwhelming majority of cases.
C Strahm, D Nadal, E Altpeter, E Bernasconi, H Furrer, J Delaloye, J Nemeth, M Abbas, M Sturzenegger, R Weber, S Erb, S Zimmerli, T Kuntzer, the for, U Heininger   +14 more
core   +3 more sources

Studying the Circulation of Etiological Agent of Lyme Borreliosis in Stavropol Region

Проблемы особо опасных инфекций, 2008
Using polymerase chain reaction with reverse transcription (RT-PCR) rRNA tick-borne borreliosis (Lyme borreliosis) etiological agent was detected in suspensions of ticks Ixodes ricinus. Infection rate was 7.1 %.
T. N. Orlova, N. F. Vasilenko, E. N. Afanasiev, I. V. Chumakova, I. V. Sannikova, A. N. Kulichenko   +5 more
doaj   +1 more source

A Fatal Case of Late Stage Lyme Borreliosis and Substance Abuse

Journal of Affective Disorders Reports, 2023
A recent study demonstrated a 1,100% (12-fold) increase in substance abuse after acquiring Lyme borreliosis. Lyme borreliosis and substance abuse have never been adequately studied and deserves greater attention.
RC Bransfield, ME Embers, AJ Dwork
doaj   +1 more source

The chemokine CXCL13 in acute neuroborreliosis [PDF]

, 2009
Objective Recent studies have suggested an important role of the B cell chemoattractant CXCL13 in acute neuroborreliosis (NB). Our aim was to confirm the diagnostic role of CXCL13 and to evaluate its relevance as a therapy response and disease activity ...
Brettschneider, Johannes, Ludolph, Albert C., Pfister, Hans-Walter, Rupprecht, Tobias A., Senel, Makbule, Tumani, Hayrettin   +5 more
core   +3 more sources

Lower Frequency of Multiple Erythema Migrans Skin Lesions in Lyme Reinfections, Europe

Emerging Infectious Diseases
The erythema migrans (EM) skin lesion is the most common clinical manifestation of Lyme borreliosis. Information about EM in Lyme borreliosis reinfection is limited.
Franc Strle, Vera Maraspin, Stanka Lotrič-Furlan, Katarina Ogrinc, Tereza Rojko, Andrej Kastrin, Klemen Strle, Gary P. Wormser, Petra Bogovič   +8 more
doaj   +1 more source

The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium

Archives of Public Health, 2017
Background In Belgium, different routine surveillance systems are in place to follow-up Lyme borreliosis trends. However, accurate data on the disease and monetary burden for the different clinical manifestations are lacking.
Laurence Geebelen, Tinne Lernout, Benoît Kabamba-Mukadi, Veroniek Saegeman, Hein Sprong, Steven Van Gucht, Philippe Beutels, Niko Speybroeck, Katrien Tersago   +8 more
doaj   +1 more source

An Enzyme-Linked Immunosorbent Spot Assay Measuring Borrelia burgdorferi B31-Specific Interferon Gamma-Secreting T Cells Cannot Discriminate Active Lyme Neuroborreliosis from Past Lyme Borreliosis: a Prospective Study in the Netherlands. [PDF]

, 2018
Two-tier serology testing is most frequently used for the diagnosis of Lyme borreliosis (LB); however, a positive result is no proof of active disease. To establish a diagnosis of active LB, better diagnostics are needed. Tests investigating the cellular
Bossink, A W J, Bouwman, J J M, Ismail, D M, Kremer, K, Muilwijk, R H, Notermans, D W, Salomons, M, Sankatsing, S U C, Thijsen, S F T, van Gorkom, T, Vlaminckx, B J M, Voet, W   +11 more
core   +1 more source